These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26811129)

  • 1. Diet and polycystic kidney disease: A pilot intervention study.
    Taylor JM; Hamilton-Reeves JM; Sullivan DK; Gibson CA; Creed C; Carlson SE; Wesson DE; Grantham JJ
    Clin Nutr; 2017 Apr; 36(2):458-466. PubMed ID: 26811129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences and Perspectives of Polycystic Kidney Disease Patients following a Diet of Reduced Osmoles, Protein, and Acid Precursors Supplemented with Water: A Qualitative Study.
    Taylor JM; Ptomey L; Hamilton-Reeves JM; Sullivan DK; Creed C; Carlson SE; Wesson DE; Grantham JJ; Gibson CA
    PLoS One; 2016; 11(8):e0161043. PubMed ID: 27537328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A Pilot Randomized Controlled Trial.
    Amro OW; Paulus JK; Noubary F; Perrone RD
    Am J Kidney Dis; 2016 Dec; 68(6):882-891. PubMed ID: 27663039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
    Côté G; Asselin-Thompstone L; Mac-Way F; René de Cotret P; Lacroix C; Desmeules S; Agharazii M
    Int Urol Nephrol; 2020 Feb; 52(2):343-349. PubMed ID: 32008201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
    Torres VE; Abebe KZ; Schrier RW; Perrone RD; Chapman AB; Yu AS; Braun WE; Steinman TI; Brosnahan G; Hogan MC; Rahbari FF; Grantham JJ; Bae KT; Moore CG; Flessner MF
    Kidney Int; 2017 Feb; 91(2):493-500. PubMed ID: 27993381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing fruits and vegetables in midlife women: a feasibility study.
    Gunn CA; Weber JL; Coad J; Kruger MC
    Nutr Res; 2013 Jul; 33(7):543-51. PubMed ID: 23827128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water prescription in autosomal dominant polycystic kidney disease: a pilot study.
    Wang CJ; Creed C; Winklhofer FT; Grantham JJ
    Clin J Am Soc Nephrol; 2011 Jan; 6(1):192-7. PubMed ID: 20876670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
    Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
    Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease.
    Wong ATY; Munt A; Allman-Farinelli M; Badve SV; Boudville N; Coolican H; Chandra AN; Coulshed S; Fernando M; Grantham J; Haloob I; Harris DCH; Hawley CM; Holt J; Johnson DW; Kumar K; Lee VW; Lonergan M; Mai J; Rangan A; Roger SD; Saravanabavan S; Sud K; Torres VE; Vilayur E; Zhang JQJ; Rangan GK
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33147804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional therapy in autosomal dominant polycystic kidney disease.
    Di Iorio BR; Cupisti A; D'Alessandro C; Bellasi A; Barbera V; Di Lullo L
    J Nephrol; 2018 Oct; 31(5):635-643. PubMed ID: 29344814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very Low-Protein Diet (VLPD) Reduces Metabolic Acidosis in Subjects with Chronic Kidney Disease: The "Nutritional Light Signal" of the Renal Acid Load.
    Di Iorio BR; Di Micco L; Marzocco S; De Simone E; De Blasio A; Sirico ML; Nardone L;
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28106712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial.
    El-Damanawi R; Lee M; Harris T; Mader LB; Bond S; Pavey H; Sandford RN; Wilkinson IB; Burrows A; Woznowski P; Ben-Shlomo Y; Karet Frankl FE; Hiemstra TF
    BMJ Open; 2018 May; 8(5):e022859. PubMed ID: 29743334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease.
    Barash I; Ponda MP; Goldfarb DS; Skolnik EY
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):693-7. PubMed ID: 20167686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of urinary parameters in advanced chronic kidney disease.
    Lorenzo Sellarés V
    Nefrologia (Engl Ed); 2019; 39(2):124-132. PubMed ID: 30236553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative Validity of a Beverage Frequency Questionnaire Used to Assess Fluid Intake in the Autosomal Dominant Polycystic Kidney Disease Population.
    Mannix C; Rangan A; Wong A; Zhang J; Allman-Farinelli M; Rangan G
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30096903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food groups associated with measured net acid excretion in community-dwelling older adults.
    Shea MK; Gilhooly CH; Dawson-Hughes B
    Eur J Clin Nutr; 2017 Mar; 71(3):420-424. PubMed ID: 27759073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
    Zittema D; Boertien WE; van Beek AP; Dullaart RP; Franssen CF; de Jong PE; Meijer E; Gansevoort RT
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of net acid excretion by use of paper strips.
    Whiting SJ; Muirhead JA
    Nutrition; 2005 Sep; 21(9):961-3. PubMed ID: 15979281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.